Contract Development Services

Feb 13, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
Feb 09, 2018
By Pharmaceutical Technology Editors
The companies will partner to further immuno-oncology research using humanized mice.
Feb 02, 2018
Pharmaceutical Technology
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
Feb 01, 2018
Pharmaceutical Technology
Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology.
Feb 01, 2018
Pharmaceutical Technology
Research suggests that working with a single contract partner can reduce development time and improve economics.
Feb 01, 2018
Pharmaceutical Technology
CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them.
Feb 01, 2018
Pharmaceutical Technology
Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.
Feb 01, 2018
By Pharmaceutical Technology Editors
Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.
Jan 26, 2018
By Pharmaceutical Technology Editors
The companies will be integrated to form the newly-branded AGC Biologics, which will specialize in customized contract development and manufacturing organization services for the scale-up and cGMP manufacture of protein-based therapeutics.
Jan 24, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
KBI Biopharma's acquisition of Elion Labs expands KBI's biophysical and analytical characterization capabilities.
native1_300x100
lorem ipsum